These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

164 related articles for article (PubMed ID: 35156207)

  • 21. Fatty liver disease and primary liver cancer: disease mechanisms, emerging therapies and the role of bariatric surgery.
    Selby LV; Ejaz A; Brethauer SA; Pawlik TM
    Expert Opin Investig Drugs; 2020 Feb; 29(2):107-110. PubMed ID: 31986920
    [No Abstract]   [Full Text] [Related]  

  • 22. Adipose Tissue-Liver Cross Talk in the Control of Whole-Body Metabolism: Implications in Nonalcoholic Fatty Liver Disease.
    Azzu V; Vacca M; Virtue S; Allison M; Vidal-Puig A
    Gastroenterology; 2020 May; 158(7):1899-1912. PubMed ID: 32061598
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Circadian Rhythms in the Pathogenesis and Treatment of Fatty Liver Disease.
    Saran AR; Dave S; Zarrinpar A
    Gastroenterology; 2020 May; 158(7):1948-1966.e1. PubMed ID: 32061597
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Prof Jörn Schattenberg sheds light on key treatment and diagnostic approaches to nonalcoholic steatohepatitis (NASH).
    Schattenberg JM
    Expert Opin Investig Drugs; 2020 Feb; 29(2):111-113. PubMed ID: 31985310
    [No Abstract]   [Full Text] [Related]  

  • 25. [Liver diseases. Non-alcoholic fatty liver disease].
    Bernal Reyes R
    Rev Gastroenterol Mex; 2010 Aug; 75 Suppl 1():181-3. PubMed ID: 20959244
    [No Abstract]   [Full Text] [Related]  

  • 26. Effect of Weight Loss, Diet, Exercise, and Bariatric Surgery on Nonalcoholic Fatty Liver Disease.
    Hannah WN; Harrison SA
    Clin Liver Dis; 2016 May; 20(2):339-50. PubMed ID: 27063273
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Nonalcoholic fatty liver disease and cardiovascular disease.
    Liu H; Lu HY
    World J Gastroenterol; 2014 Jul; 20(26):8407-15. PubMed ID: 25024598
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Molecular mechanisms of nonalcoholic fatty liver disease: Potential role for 12-lipoxygenase.
    Samala N; Tersey SA; Chalasani N; Anderson RM; Mirmira RG
    J Diabetes Complications; 2017 Nov; 31(11):1630-1637. PubMed ID: 28886991
    [TBL] [Abstract][Full Text] [Related]  

  • 29. NASH Syndrome: The Coming Epidemic.
    Dominguez C
    Gastroenterol Nurs; 2018; 41(4):316-320. PubMed ID: 30063688
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Obesity and nonalcoholic fatty liver disease: From pathophysiology to therapeutics.
    Polyzos SA; Kountouras J; Mantzoros CS
    Metabolism; 2019 Mar; 92():82-97. PubMed ID: 30502373
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Endocrine causes of nonalcoholic fatty liver disease.
    Marino L; Jornayvaz FR
    World J Gastroenterol; 2015 Oct; 21(39):11053-76. PubMed ID: 26494962
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Non-alcoholic fatty liver disease.
    Pearce L
    Nurs Stand; 2016 Aug; 30(52):15. PubMed ID: 27641564
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Exercise-Induced Autophagy in Fatty Liver Disease.
    Chun SK; Lee S; Yang MJ; Leeuwenburgh C; Kim JS
    Exerc Sport Sci Rev; 2017 Jul; 45(3):181-186. PubMed ID: 28419000
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Nonalcoholic fatty liver disease: another leap forward.
    Abdelmalek MF
    Nat Rev Gastroenterol Hepatol; 2021 Feb; 18(2):85-86. PubMed ID: 33420415
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Weight loss enhances hepatic antioxidant status in a NAFLD model induced by high-fat diet.
    Mendes IKS; Matsuura C; Aguila MB; Daleprane JB; Martins MA; Mury WV; Brunini TMC
    Appl Physiol Nutr Metab; 2018 Jan; 43(1):23-29. PubMed ID: 28834687
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Energy-matched moderate and high intensity exercise training improves nonalcoholic fatty liver disease risk independent of changes in body mass or abdominal adiposity - A randomized trial.
    Winn NC; Liu Y; Rector RS; Parks EJ; Ibdah JA; Kanaley JA
    Metabolism; 2018 Jan; 78():128-140. PubMed ID: 28941598
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Fat and Sugar-A Dangerous Duet. A Comparative Review on Metabolic Remodeling in Rodent Models of Nonalcoholic Fatty Liver Disease.
    Simoes ICM; Janikiewicz J; Bauer J; Karkucinska-Wieckowska A; Kalinowski P; Dobrzyń A; Wolski A; Pronicki M; Zieniewicz K; Dobrzyń P; Krawczyk M; Zischka H; Wieckowski MR; Potes Y
    Nutrients; 2019 Nov; 11(12):. PubMed ID: 31771244
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Cutting out the liver fat.
    Nat Med; 2017 Dec; 23(12):1385. PubMed ID: 29216035
    [No Abstract]   [Full Text] [Related]  

  • 39. Non-alcoholic fatty liver disease and obesity: biochemical, metabolic and clinical presentations.
    Milić S; Lulić D; Štimac D
    World J Gastroenterol; 2014 Jul; 20(28):9330-7. PubMed ID: 25071327
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Nutrition and Physical Activity in Nonalcoholic Fatty Liver Disease.
    Oliveira CP; de Lima Sanches P; de Abreu-Silva EO; Marcadenti A
    J Diabetes Res; 2016; 2016():4597246. PubMed ID: 26770987
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 9.